Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derk J Hogenkamp

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The Journal of Pharmacology and Experimental Therapeutics|September 18, 2007
Negative allosteric modulation of nicotinic acetylcholine receptors blocks nicotine self-administration in ratsRyan F Yoshimura, Derk J Hogenkamp, Wen Y Li, et al.
Journal of Medicinal Chemistry|June 19, 2007
Enaminone amides as novel orally active GABAA receptor modulatorsDerk J Hogenkamp, Timothy B C Johnstone, Jin-Cheng Huang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2007
Nootropic alpha7 nicotinic receptor allosteric modulator derived from GABAA receptor modulatorsHerman J Ng, Edward R Whittemore, Minhtam B Tran, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 27, 2009
Limiting activity at beta1-subunit-containing GABAA receptor subtypes reduces ataxiaKelvin W Gee, Minhtam B Tran, Derk J Hogenkamp, et al.
Nature Medicine|December 3, 2003
Modifying quinolone antibiotics yields new anxiolyticsTimothy B C Johnstone, Derk J Hogenkamp, Leanne Coyne, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 17, 2010
Allosteric modulation of related ligand-gated ion channels synergistically induces long-term potentiation in the hippocampus and enhances cognitionTimothy B Johnstone, Zhenglin Gu, Ryan F Yoshimura, et al.
Journal of Medicinal Chemistry|October 9, 2013
Design, synthesis, and activity of a series of arylpyrid-3-ylmethanones as type I positive allosteric modulators of α7 nicotinic acetylcholine receptorsDerk J Hogenkamp, Thomas A Ford-Hutchinson, Wen-Yen Li, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 27, 2006
Pharmacology of 2-[4-(4-chloro-2-fluorophenoxy)phenyl]-pyrimidine-4-carboxamide: a potent, broad-spectrum state-dependent sodium channel blocker for treating pain statesVictor I Ilyin, James D Pomonis, Garth T Whiteside, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The Journal of Pharmacology and Experimental Therapeutics|September 18, 2007
Negative allosteric modulation of nicotinic acetylcholine receptors blocks nicotine self-administration in ratsRyan F Yoshimura, Derk J Hogenkamp, Wen Y Li, et al.
Journal of Medicinal Chemistry|June 19, 2007
Enaminone amides as novel orally active GABAA receptor modulatorsDerk J Hogenkamp, Timothy B C Johnstone, Jin-Cheng Huang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2007
Nootropic alpha7 nicotinic receptor allosteric modulator derived from GABAA receptor modulatorsHerman J Ng, Edward R Whittemore, Minhtam B Tran, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 27, 2009
Limiting activity at beta1-subunit-containing GABAA receptor subtypes reduces ataxiaKelvin W Gee, Minhtam B Tran, Derk J Hogenkamp, et al.
Nature Medicine|December 3, 2003
Modifying quinolone antibiotics yields new anxiolyticsTimothy B C Johnstone, Derk J Hogenkamp, Leanne Coyne, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 17, 2010
Allosteric modulation of related ligand-gated ion channels synergistically induces long-term potentiation in the hippocampus and enhances cognitionTimothy B Johnstone, Zhenglin Gu, Ryan F Yoshimura, et al.
Journal of Medicinal Chemistry|October 9, 2013
Design, synthesis, and activity of a series of arylpyrid-3-ylmethanones as type I positive allosteric modulators of α7 nicotinic acetylcholine receptorsDerk J Hogenkamp, Thomas A Ford-Hutchinson, Wen-Yen Li, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 27, 2006
Pharmacology of 2-[4-(4-chloro-2-fluorophenoxy)phenyl]-pyrimidine-4-carboxamide: a potent, broad-spectrum state-dependent sodium channel blocker for treating pain statesVictor I Ilyin, James D Pomonis, Garth T Whiteside, et al.
Pageof 2